WuXi XDC Cayman Inc (2268.HK)
- Previous Close
20.000 - Open
20.400 - Bid 20.500 x --
- Ask 20.600 x --
- Day's Range
19.820 - 20.900 - 52 Week Range
12.080 - 34.000 - Volume
2,757,509 - Avg. Volume
3,562,716 - Market Cap (intraday)
24.551B - Beta (5Y Monthly) --
- PE Ratio (TTM)
73.21 - EPS (TTM)
0.280 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
31.00
WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.
wuxixdc.com1,178
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2268.HK
Performance Overview: 2268.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2268.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2268.HK
Valuation Measures
Market Cap
24.55B
Enterprise Value
20.18B
Trailing P/E
72.96
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.63
Price/Book (mrq)
4.17
Enterprise Value/Revenue
9.50
Enterprise Value/EBITDA
56.00
Financial Highlights
Profitability and Income Statement
Profit Margin
13.35%
Return on Assets (ttm)
4.95%
Return on Equity (ttm)
8.18%
Revenue (ttm)
2.12B
Net Income Avi to Common (ttm)
283.54M
Diluted EPS (ttm)
0.280
Balance Sheet and Cash Flow
Total Cash (mrq)
4.05B
Total Debt/Equity (mrq)
0.05%
Levered Free Cash Flow (ttm)
--
Research Analysis: 2268.HK
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 2268.HK
2268.HK does not have Company Insights